Cancer Cell Q1 Unclaimed

Cell Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Cell is a journal indexed in SJR in Cell Biology and Oncology with an H index of 316. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 4704 €. The scope of the journal is focused on Cancer, Cancer Cell, Cancer Biology. It has an SJR impact factor of 11,909 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

4704 €

Gold OA

-

Green OA

- €

Non OA

Metrics

Cancer Cell

11,909

SJR Impact factor

316

H Index

158

Total Docs (Last Year)

581

Total Docs (3 years)

7507

Total Refs

10078

Total Cites (3 years)

532

Citable Docs (3 years)

18,59

Cites/Doc (2 years)

47,51

Ref/Doc

Aims and Scope


Cancer Cancer Cell Cancer Biology


Best articles

(Re-)Engineering tumor cell-selective replicating adenoviruses: A step in the right direction toward systemic therapy for metastatic disease

View more

A big step in the study of small cell lung cancer

View more

A dance between interferon-a/beta and p53 demonstrates collaborations in tumor suppression and antiviral activities

View more

A Malignant Oligarchy: Progenitors Govern the Behavior of Oligodendrogliomas

View more

A new anti-ErbB2 strategy in the treatment of cancer: Prevention of ligand-dependent ErbB2 receptor heterodimerization

View more

Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes

View more

An exciting forum for cancer research

View more

Antagonism of Myc functions by Arf

View more

Antagonizing XIAP-mediated caspase-3 inhibition

View more

Antiangiogenic therapy and tumor progression

View more

BH3 domains: intracellular death-ligands critical for initiating apoptosis

View more

BLIMP1 against Lymphoma: The Verdict Is Reached

View more
SHOW MORE ARTICLES

BRAF as a potential therapeutic target in melanoma and other malignancies

View more

Breast cancer susceptibility - A new look at an old model

View more

Building through Breaking: The Development of Cancer Neochromosomes

View more

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

View more

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

View more

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

View more

Cdk2 dethroned as master of S phase entry

View more

Cell cycle progression without cyclin E/CDK2

View more

Cesar Milstein: October 8, 1927-March 24, 2002

View more

ChIP-ping Away at EWS/ETS Transcription Networks

View more

Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer

View more

Considering the cancer consequences of altered DNA polymerase function

View more

Comments

No comments ... Be the first to comment!